The SARS-CoV-2 Coronavirus and the COVID-19 outbreak

Autores
Lauxmann, Martin Alexander; Santucci, Natalia Estefanía; Autrán Gómez, Ana María
Año de publicación
2020
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
The SARS-CoV-2, a newly identified β-coronavirus, is the causative agent of the third large-scale pandemic from the last two decades. The outbreak started in December 2019 in Wuhan City, Hubei province in China. The patients presented clinical symptoms of dry cough, fever, dyspnea, and bilateral lung infiltrates on imaging. By February 2020, The World Health Organization (WHO) named the disease as Coronavirus Disease 2019 (COVID-19). The Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses (ICTV) recognized and designated this virus as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 uses the same host receptor, angiotensin-converting enzyme 2 (ACE2), used by SARS-CoV to infecthumans. One hypothesis of SARSCoV-2 origin indicates that it is likely that bats serve as reservoir hosts for SARSCoV-2, being the intermediate host not yet determined. The predominant route of transmission of SARS-CoV-2 is from human to human. As of May 10th 2020, the number of worldwide confirmed COVID-19 cases is over 4 million, while the number of global deaths is around 279.000 people. The United States of America (USA) has the highest number of COVID-19 cases with over 1.3 million cases followed by Spain, Italy, United Kingdom, Russia, France and Germany with over 223.000, 218.000, 215.000, 209.000, 176.000, and 171.000 cases, respectively.
Fil: Lauxmann, Martin Alexander. Medizinische Hochschule Brandenburg Theodor Fontane.; Alemania. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Santucci, Natalia Estefanía. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Inmunología Clinica y Experimental de Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Médicas. Instituto de Inmunología Clinica y Experimental de Rosario; Argentina
Fil: Autrán Gómez, Ana María. Hospital Universitario Fundación Jiménez Díaz; España
Materia
CORONAVIRUS
SPIKE PROTEIN
SARS-COV-2
DIAGNOSIS
COVID-19
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/135520
Acceder
id CONICETDig_5b6b10c1a5f8bfbe0677861d7697af0b
oai_identifier_str oai:ri.conicet.gov.ar:11336/135520
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling The SARS-CoV-2 Coronavirus and the COVID-19 outbreakLauxmann, Martin AlexanderSantucci, Natalia EstefaníaAutrán Gómez, Ana MaríaCORONAVIRUSSPIKE PROTEINSARS-COV-2DIAGNOSISCOVID-19https://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1The SARS-CoV-2, a newly identified β-coronavirus, is the causative agent of the third large-scale pandemic from the last two decades. The outbreak started in December 2019 in Wuhan City, Hubei province in China. The patients presented clinical symptoms of dry cough, fever, dyspnea, and bilateral lung infiltrates on imaging. By February 2020, The World Health Organization (WHO) named the disease as Coronavirus Disease 2019 (COVID-19). The Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses (ICTV) recognized and designated this virus as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 uses the same host receptor, angiotensin-converting enzyme 2 (ACE2), used by SARS-CoV to infecthumans. One hypothesis of SARSCoV-2 origin indicates that it is likely that bats serve as reservoir hosts for SARSCoV-2, being the intermediate host not yet determined. The predominant route of transmission of SARS-CoV-2 is from human to human. As of May 10th 2020, the number of worldwide confirmed COVID-19 cases is over 4 million, while the number of global deaths is around 279.000 people. The United States of America (USA) has the highest number of COVID-19 cases with over 1.3 million cases followed by Spain, Italy, United Kingdom, Russia, France and Germany with over 223.000, 218.000, 215.000, 209.000, 176.000, and 171.000 cases, respectively.Fil: Lauxmann, Martin Alexander. Medizinische Hochschule Brandenburg Theodor Fontane.; Alemania. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Santucci, Natalia Estefanía. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Inmunología Clinica y Experimental de Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Médicas. Instituto de Inmunología Clinica y Experimental de Rosario; ArgentinaFil: Autrán Gómez, Ana María. Hospital Universitario Fundación Jiménez Díaz; EspañaSociedade Brasileira de Urologia2020-06-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/135520Lauxmann, Martin Alexander; Santucci, Natalia Estefanía; Autrán Gómez, Ana María; The SARS-CoV-2 Coronavirus and the COVID-19 outbreak; Sociedade Brasileira de Urologia; International Brazilian Journal of Urology; 46; 1; 5-6-2020; 6-181677-55381677-6119CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1590/s1677-5538.ibju.2020.s101info:eu-repo/semantics/altIdentifier/url/https://www.scielo.br/j/ibju/a/ymkTGVgBVd3ZhQLdVgMVQsQ/?lang=eninfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:04:41Zoai:ri.conicet.gov.ar:11336/135520instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:04:42.037CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv The SARS-CoV-2 Coronavirus and the COVID-19 outbreak
title The SARS-CoV-2 Coronavirus and the COVID-19 outbreak
spellingShingle The SARS-CoV-2 Coronavirus and the COVID-19 outbreak
Lauxmann, Martin Alexander
CORONAVIRUS
SPIKE PROTEIN
SARS-COV-2
DIAGNOSIS
COVID-19
title_short The SARS-CoV-2 Coronavirus and the COVID-19 outbreak
title_full The SARS-CoV-2 Coronavirus and the COVID-19 outbreak
title_fullStr The SARS-CoV-2 Coronavirus and the COVID-19 outbreak
title_full_unstemmed The SARS-CoV-2 Coronavirus and the COVID-19 outbreak
title_sort The SARS-CoV-2 Coronavirus and the COVID-19 outbreak
dc.creator.none.fl_str_mv Lauxmann, Martin Alexander
Santucci, Natalia Estefanía
Autrán Gómez, Ana María
author Lauxmann, Martin Alexander
author_facet Lauxmann, Martin Alexander
Santucci, Natalia Estefanía
Autrán Gómez, Ana María
author_role author
author2 Santucci, Natalia Estefanía
Autrán Gómez, Ana María
author2_role author
author
dc.subject.none.fl_str_mv CORONAVIRUS
SPIKE PROTEIN
SARS-COV-2
DIAGNOSIS
COVID-19
topic CORONAVIRUS
SPIKE PROTEIN
SARS-COV-2
DIAGNOSIS
COVID-19
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv The SARS-CoV-2, a newly identified β-coronavirus, is the causative agent of the third large-scale pandemic from the last two decades. The outbreak started in December 2019 in Wuhan City, Hubei province in China. The patients presented clinical symptoms of dry cough, fever, dyspnea, and bilateral lung infiltrates on imaging. By February 2020, The World Health Organization (WHO) named the disease as Coronavirus Disease 2019 (COVID-19). The Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses (ICTV) recognized and designated this virus as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 uses the same host receptor, angiotensin-converting enzyme 2 (ACE2), used by SARS-CoV to infecthumans. One hypothesis of SARSCoV-2 origin indicates that it is likely that bats serve as reservoir hosts for SARSCoV-2, being the intermediate host not yet determined. The predominant route of transmission of SARS-CoV-2 is from human to human. As of May 10th 2020, the number of worldwide confirmed COVID-19 cases is over 4 million, while the number of global deaths is around 279.000 people. The United States of America (USA) has the highest number of COVID-19 cases with over 1.3 million cases followed by Spain, Italy, United Kingdom, Russia, France and Germany with over 223.000, 218.000, 215.000, 209.000, 176.000, and 171.000 cases, respectively.
Fil: Lauxmann, Martin Alexander. Medizinische Hochschule Brandenburg Theodor Fontane.; Alemania. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Santucci, Natalia Estefanía. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Inmunología Clinica y Experimental de Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Médicas. Instituto de Inmunología Clinica y Experimental de Rosario; Argentina
Fil: Autrán Gómez, Ana María. Hospital Universitario Fundación Jiménez Díaz; España
description The SARS-CoV-2, a newly identified β-coronavirus, is the causative agent of the third large-scale pandemic from the last two decades. The outbreak started in December 2019 in Wuhan City, Hubei province in China. The patients presented clinical symptoms of dry cough, fever, dyspnea, and bilateral lung infiltrates on imaging. By February 2020, The World Health Organization (WHO) named the disease as Coronavirus Disease 2019 (COVID-19). The Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses (ICTV) recognized and designated this virus as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 uses the same host receptor, angiotensin-converting enzyme 2 (ACE2), used by SARS-CoV to infecthumans. One hypothesis of SARSCoV-2 origin indicates that it is likely that bats serve as reservoir hosts for SARSCoV-2, being the intermediate host not yet determined. The predominant route of transmission of SARS-CoV-2 is from human to human. As of May 10th 2020, the number of worldwide confirmed COVID-19 cases is over 4 million, while the number of global deaths is around 279.000 people. The United States of America (USA) has the highest number of COVID-19 cases with over 1.3 million cases followed by Spain, Italy, United Kingdom, Russia, France and Germany with over 223.000, 218.000, 215.000, 209.000, 176.000, and 171.000 cases, respectively.
publishDate 2020
dc.date.none.fl_str_mv 2020-06-05
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/135520
Lauxmann, Martin Alexander; Santucci, Natalia Estefanía; Autrán Gómez, Ana María; The SARS-CoV-2 Coronavirus and the COVID-19 outbreak; Sociedade Brasileira de Urologia; International Brazilian Journal of Urology; 46; 1; 5-6-2020; 6-18
1677-5538
1677-6119
CONICET Digital
CONICET
url http://hdl.handle.net/11336/135520
identifier_str_mv Lauxmann, Martin Alexander; Santucci, Natalia Estefanía; Autrán Gómez, Ana María; The SARS-CoV-2 Coronavirus and the COVID-19 outbreak; Sociedade Brasileira de Urologia; International Brazilian Journal of Urology; 46; 1; 5-6-2020; 6-18
1677-5538
1677-6119
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1590/s1677-5538.ibju.2020.s101
info:eu-repo/semantics/altIdentifier/url/https://www.scielo.br/j/ibju/a/ymkTGVgBVd3ZhQLdVgMVQsQ/?lang=en
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Sociedade Brasileira de Urologia
publisher.none.fl_str_mv Sociedade Brasileira de Urologia
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269870367965184
score 12.885934

Publicaciones similares